Carin D. Sandvik is an independent financial consultant who is currently acting as the Company’s Chief Financial Officer. For the past year, Ms. Sandvik has been working as an independent consultant to biotechnology companies located in the San Diego area. Prior to this, she served as the Vice President for Finance & Administration at Corautus Genetics, Inc., a publicly-traded biotechnology company. novarx
